-
Founded in:
2008-09-03 -
Country:
China -
Address:
No. 2001 Tushan Road, Bengbu City, Anhui Province -
Tax NO.:
913403006789356353 -
Registered Funds:
88 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Epimedium P.E Icariin 10%,20% HPLC |
Nourishes the kidneys and strengthens the body
More
Nourishes the kidneys and strengthens the body |
0 | ||
| Cuscutae Semen |
Nourishes the kidneys and strengthens the body
More
Nourishes the kidneys and strengthens the body |
0 | ||
| Rosae Laevigatae Fructus |
Nourishes the kidneys and strengthens the body
More
Nourishes the kidneys and strengthens the body |
0 | ||
| Ligustrum |
Nourishes the kidneys and strengthens the body
More
Nourishes the kidneys and strengthens the body |
0 | ||
| Chinois ridge (scalding) |
Nourishes the kidneys and strengthens the body
More
Nourishes the kidneys and strengthens the body |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Bupleurum |
|
0 | ||
| Kawana |
|
0 | ||
| Argy Wormwood Leaf |
|
0 | ||
| Dehydroandrographolide |
|
134418-28-3 | 0 | |
| Epimedium P.E Icariin 10%,20% HPLC |
|
0 | ||
| Asparagus cochinchinensis |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Rifampicin |
The antibacterial spectrum is similar to that of rifampicin. It has good antibacterial activity against tuberculosis and leprosy. When the dosage is 1/3 of that of rifampicin, similar or higher efficacy can be achieved. It has a good effect on Staphylococcus aureus and has certain antibacterial activity against some Escherichia coli. In addition, it also has an inhibitory effect on Chlamydia trachomatis.
More
The antibacterial spectrum is similar to that of rifampicin. It has good antibacterial activity against tuberculosis and leprosy. When the dosage is 1/3 of that of rifampicin, similar or higher efficacy can be achieved. It has a good effect on Staphylococcus aureus and has certain antibacterial activity against some Escherichia coli. In addition, it also has an inhibitory effect on Chlamydia trachomatis. |
13292-46-1 | 24 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Naftopidil dihydrochloride |
A selective α1 receptor antagonist that can inhibit the rise in blood pressure caused by α1 receptors, has a hypotensive effect on a variety of hypertensive animal models, has a long duration of hypotensive effect, does not cause reflex tachycardia during hypotensive treatment, and has no obvious first-dose effect or drug resistance after multiple oral administrations. It can reduce the total peripheral resistance of anesthetized open-chest dogs, dilate peripheral blood vessels, and has no significant effect on cardiac output. It can also relieve the sympathetic tension of the prostate and urethra caused by the excitement of the receptor through the α1 receptor blocking effect, reduce the intraurethral pressure, and improve symptoms such as urination disorders caused by benign prostatic hyperplasia.
More
A selective α1 receptor antagonist that can inhibit the rise in blood pressure caused by α1 receptors, has a hypotensive effect on a variety of hypertensive animal models, has a long duration of hypotensive effect, does not cause reflex tachycardia during hypotensive treatment, and has no obvious first-dose effect or drug resistance after multiple oral administrations. It can reduce the total peripheral resistance of anesthetized open-chest dogs, dilate peripheral blood vessels, and has no significant effect on cardiac output. It can also relieve the sympathetic tension of the prostate and urethra caused by the excitement of the receptor through the α1 receptor blocking effect, reduce the intraurethral pressure, and improve symptoms such as urination disorders caused by benign prostatic hyperplasia. |
57149-07-2 | 13 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Zaleplon |
Extract from the above information
More
Extract from the above information |
0 |